Adage Capital Partners
NPSP

Adage Capital Partners’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Adage Capital Partners’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-300,000
Closed -$9.11M – 772
2013
Q4 		$9.11M Hold
300,000
– – 0.02% 533
2013
Q3 		$9.54M Buy
+300,000
New +$6.88M 0.03% 511

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Adage Capital Partners's NPSP Position: Q1 2014 in Review

Adage Capital Partners sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2014, closing a stake of 300,000 shares — an estimated $9.11M sold.

Adage Capital Partners first reported a position in NPSP in Q3 2013 and held it in 2 quarters. The position peaked at $9.54M in Q3 2013. 210 funds tracked by Wall St. Rank hold NPSP as of Q1 2014.

  • Adage Capital Partners reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Adage Capital Partners sold 300,000 NPS PHARMACEUTICALS INC shares in Q1 2014, an estimated $9.11M.
  • Adage Capital Partners first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
  • Adage Capital Partners's NPS PHARMACEUTICALS INC position peaked at $9.54M in Q3 2013.
  • 210 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2014.

Based on Adage Capital Partners's 13F filing for Q1 2014, filed 15 May 2014.